Anaplastic thyroid carcinoma ranges from 1.3 to 9.8% of all thyroid cancers globally.
Mutations, amplifications, activation of oncogenes and silencing of tumour suppressor genes …

Anaplastic thyroid cancer (ATC) is a rare malignancy. While external beam radiation therapy
has improved locoregional control, the median survival of∼ 4 months has not changed in …

Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid
cancer. Since the guidelines for the management of ATC by the American Thyroid …

BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …

Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid
cancer. Rapid evaluation and establishment of treatment goals are imperative for optimum …

Anaplastic thyroid cancer (ATC) is an infrequent thyroid tumor that usually occurs in elderly
patients. There is often a history of previous differentiated thyroid cancer suggesting a …

Background: Anaplastic thyroid carcinoma (ATC) is a malignancy with one of the highest
fatality rates. Here we report a retrospective study of the treatment and other factors …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were …

Anaplastic thyroid carcinoma is one of the most aggressive and deadly cancers in humans
and accounts for one to two cases per million persons annually. The rarity of this malignancy …

Anaplastic thyroid carcinoma (ATC) is the rarest, but deadliest histologic type among thyroid
malignancies, with a dismal median survival of 3-9 mo. Even though ATC accounts for less …